Adverse dermatologic reactions to transdermal drug delivery systems

J Am Acad Dermatol. 1990 May;22(5 Pt 1):811-4. doi: 10.1016/0190-9622(90)70113-v.

Abstract

Transdermal drug delivery systems are marketed in the United States for four different drugs, and others are in various stages of development. Cutaneous side effects occur frequently with these systems and sometimes necessitate discontinuation of therapy. This article will review these adverse reactions.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous*
  • Clonidine / administration & dosage
  • Dermatitis, Contact / etiology*
  • Estradiol / administration & dosage
  • Forecasting
  • Humans
  • Nitroglycerin / administration & dosage
  • Scopolamine / administration & dosage
  • Time Factors

Substances

  • Estradiol
  • Scopolamine
  • Nitroglycerin
  • Clonidine